LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Metabolic Improvements and Remission of Prediabetes and Type 2 Diabetes: Results From a Multidomain Lifestyle Intervention Clinic.

    Iglesies-Grau, Josep / Dionne, Valérie / Bherer, Louis / Bouabdallaoui, Nadia / Aubut, Lise / Besnier, Florent / Bertholet, Johanne / Berthiaume, Annie / Bisaillon, Marc / Gayda, Mathieu / Gagnon, Christine / Hamrioui, Nacima / Latour, Élise / L'Allier, Philippe L / Marie-Hélène, Morissette C / Nigam, Anil / Pelletier, Véronique / Tessier, Geneviève / Juneau, Martin

    Canadian journal of diabetes

    2022  Volume 47, Issue 2, Page(s) 185–189

    Abstract: Objectives: Although lifestyle interventions are first-line treatment for individuals living with prediabetes and type 2 diabetes (T2D), they are rarely implemented effectively in routine clinical care.: Methods: We present a retrospective analysis ... ...

    Abstract Objectives: Although lifestyle interventions are first-line treatment for individuals living with prediabetes and type 2 diabetes (T2D), they are rarely implemented effectively in routine clinical care.
    Methods: We present a retrospective analysis of a 12-month, single-centre, structured multidomain lifestyle intervention clinic offered to individuals living with prediabetes and type 2 diabetes. The intervention consisted of expert-guided educational and nutritional counselling combined with a personalized physical exercise prescription, with the main goal of improving metabolic health and reaching remission. Anthropometric parameters, glucose, basal insulin, glycated hemoglobin (A1C), and lipid levels were measured at baseline and at 3, 6, and 12 months after the lifestyle intervention initiation. Remission of prediabetes and T2D were defined as a return of A1C at 6 months to <6.5% (or <5.7% for prediabetes) and persisting for at least 3 months in the absence of glucose-lowering pharmacotherapy.
    Results: After a multidomain, expert-guided lifestyle intervention, 117 individuals living with prediabetes and T2D had significantly improved metabolic profiles: Mean weight change at 12 months was -4.9 kg (95% confidence interval [CI], -4.0 to -5.7; p<0.001), and mean change in A1C at 12 months was -0.6% (95% CI, -0.4 to -0.7; p<0.001). A substantial proportion of individuals reached the criteria for remission (20% among participants with prediabetes and 12% among those with T2D).
    Conclusions: The results of this study suggest that prioritizing lifestyle changes in a multifaceted, progressive, 12-month intervention in this population improves anthropometric and insulin resistance measures, and has the potential to normalize metabolic values, even to the point of reaching the criteria of remission.
    MeSH term(s) Humans ; Diabetes Mellitus, Type 2/therapy ; Prediabetic State ; Glycated Hemoglobin ; Retrospective Studies ; Blood Glucose/metabolism ; Life Style ; Glucose
    Chemical Substances Glycated Hemoglobin ; Blood Glucose ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-11-03
    Publishing country Canada
    Document type Journal Article
    ISSN 2352-3840
    ISSN (online) 2352-3840
    DOI 10.1016/j.jcjd.2022.10.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Etiology and outcome of acute liver failure: experience from a liver transplantation centre in Montreal.

    Tessier, Geneviève / Villeneuve, Edith / Villeneuve, Jean-Pierre

    Canadian journal of gastroenterology = Journal canadien de gastroenterologie

    2002  Volume 16, Issue 10, Page(s) 672–676

    Abstract: Background: Acute liver failure is a rare condition in which massive liver injury is associated with the rapid development of hepatic encephalopathy. Although viral hepatitis and drug-induced liver injury are the most common causes, no specific etiology ...

    Abstract Background: Acute liver failure is a rare condition in which massive liver injury is associated with the rapid development of hepatic encephalopathy. Although viral hepatitis and drug-induced liver injury are the most common causes, no specific etiology is found in a substantial proportion of cases reported from Europe and the United States.
    Aim: To determine the etiology and outcome of patients with acute liver failure in the authors' institution.
    Patients and methods: The charts of 81 consecutive patients admitted to Saint-Luc between 1991 and 1999 were reviewed.
    Results: The etiology was viral in 27 cases (33.2%), toxic or drug-induced in 22 (27.2%), of unknown origin in 22 (27.2%) and due to various causes in 10 (12.3%) (autoimmune, vascular, cancer). Of the 81 patients, 16% survived without liver transplantation, and 84% died or underwent liver transplantation. Survival without liver transplantation differed according to the mode of presentation: the survival rate was 27% in patients with hyperacute liver failure, 7% in those with acute liver failure and 0% in those with subacute liver failure. Among the 38 patients who underwent liver transplantation, survival one year after transplantation was 71%. In the 30 patients who died without liver transplantation, the main causes of death were cerebral edema and sepsis.
    Conclusions: Acute liver failure is associated with a high mortality, and liver transplantation is the treatment of choice. In a significant proportion of cases, the etiology remains undetermined and is probably related to yet unidentified hepatotropic viruses.
    MeSH term(s) Adult ; Age Distribution ; Aged ; Cause of Death ; Female ; Graft Rejection ; Graft Survival ; Hospital Units ; Humans ; Liver Failure, Acute/etiology ; Liver Failure, Acute/mortality ; Liver Failure, Acute/surgery ; Liver Function Tests ; Liver Transplantation/adverse effects ; Liver Transplantation/methods ; Male ; Middle Aged ; Patient Selection ; Postoperative Complications/mortality ; Quebec ; Retrospective Studies ; Risk Assessment ; Severity of Illness Index ; Sex Distribution ; Survival Rate
    Language English
    Publishing date 2002-09-27
    Publishing country Canada
    Document type Comparative Study ; Journal Article
    ZDB-ID 639439-5
    ISSN 1916-7237 ; 0835-7900
    ISSN (online) 1916-7237
    ISSN 0835-7900
    DOI 10.1155/2002/328415
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: EUS-guided pancreatogastrostomy and pancreatobulbostomy for the treatment of pain in patients with pancreatic ductal dilatation inaccessible for transpapillary endoscopic therapy.

    Tessier, Geneviève / Bories, Erwan / Arvanitakis, Marianna / Hittelet, Axel / Pesenti, Christian / Le Moine, Olivier / Giovannini, Marc / Devière, Jacques

    Gastrointestinal endoscopy

    2007  Volume 65, Issue 2, Page(s) 233–241

    Abstract: Background: EUS-guided pancreatogastrostomy (EPG) is described as an alternative to surgery for ductal decompression in symptomatic patients when endoscopic transpapillary access of the main pancreatic duct (MPD) is impossible.: Objective: To present ...

    Abstract Background: EUS-guided pancreatogastrostomy (EPG) is described as an alternative to surgery for ductal decompression in symptomatic patients when endoscopic transpapillary access of the main pancreatic duct (MPD) is impossible.
    Objective: To present the midterm clinical response and follow-up of a larger group of patients treated with EPG and a new transbulbar approach, EUS-guided pancreatobulbostomy (EPB).
    Design: Retrospective case review.
    Setting: Two tertiary referral centers in Brussels and Marseille.
    Patients: From 2000 to 2004, 36 patients (51 years old; range, 14-71 years) were seen.
    Intervention: EPG or EPB.
    Main outcome measurements: Pain relief, technical aspects, complications, and clinical follow-up.
    Results: Indications were chronic pancreatitis, with complete obstruction (secondary to a tight stenosis, a stone, or MPD rupture); inaccessible papilla or impossible cannulation (n = 20); anastomotic stenosis after a Whipple procedure (n = 12); complete MPD rupture after acute pancreatitis (AP); or trauma (n = 4). EPG or EPB was unsuccessful in 3 patients; 1 was lost to follow-up. Major complications occurred in 2 patients and included 1 hematoma and 1 severe AP. The median follow-up was 14.5 months (range, 4-55 months). Pain relief was complete or partial in 25 patients (69%, intention to treat). Eight patients treated had no improvement of their symptoms (4 were subsequently diagnosed with cancer). Stent dysfunction occurred in 20 patients (55%) and required a total of 29 repeat endoscopies.
    Limitations: Technically demanding and requires careful pretherapeutic evaluation.
    Conclusions: EPG or EPB appears to be an effective and relatively safe treatment for the management of pain secondary to pancreatic ductal hypertension in patients with an MPD not accessible by a transpapillary route.
    MeSH term(s) Abdominal Pain/etiology ; Adolescent ; Adult ; Aged ; Cholangiopancreatography, Endoscopic Retrograde ; Constriction, Pathologic/therapy ; Dilatation, Pathologic/etiology ; Dilatation, Pathologic/therapy ; Endoscopy, Gastrointestinal ; Endosonography ; Female ; Humans ; Male ; Middle Aged ; Pancreatic Diseases/complications ; Pancreatic Diseases/therapy ; Pancreatic Ducts ; Retrospective Studies ; Stents
    Language English
    Publishing date 2007-02
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 391583-9
    ISSN 1097-6779 ; 0016-5107
    ISSN (online) 1097-6779
    ISSN 0016-5107
    DOI 10.1016/j.gie.2006.06.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top